Inhibition of bone resorption and lysosomal enzyme release from calvarial bones cultured for 24 hours: synergism between cyclic AMP analogues and phosphodiesterase inhibitors.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects / Q000201:enzymology*; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000031:analogs & derivatives* / Q000494:pharmacology; D004357:Drug Synergism; D008247:Lysosomes / Q000201:enzymology; D051379:Mice; D009924:Organ Culture Techniques; D010281:Parathyroid Hormone / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D013806:Theophylline / Q000494:pharmacology*; D013997:Time Factors
D010281:Parathyroid Hormone; D010726:Phosphodiesterase Inhibitors; D003994:Bucladesine; D013806:Theophylline; D000242:Cyclic AMP; D002118:Calcium; D015056:1-Methyl-3-isobutylxanthine